Thrombolytic drugs may be an alternative therapy for acute limb ischemia in patients who are not surgically treatable.
Two cases of acute limb ischemia managed successfully with a sequential intraarterial infusion of urokinase and recombinant-type tissue plasminogen activator (rt-TPA) are reported.
The positive results suggest the two drugs have a synergistic action. Further studies are needed to demonstrate the interactions between these thrombolytic agents
References
1.
Dryjski M., Swedenborg J.: Acute thrombosis and embolism of the extremities: Factors influencing the result of treatment. Acta Chir Scand148:135-139, 1982
2.
Elliott JP, Hageman Jh, Szilagyi DE, et al: Arterial embolization: Problems of source, multiplicity, recurrence and delayed treatment. Surgery88:833-845, 1980.
3.
Collen D., Van De Werf F.: Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction . Am J Cardiol60:431-434, 1987.
4.
Collen D., De Cock F., Demarsin E., et al: Absence of Synergysm between tissue-type plasminogen activator (t-PA), single chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro. Thromb Haemost56:35-39, 1986.
5.
Spriggs DJ, Stassen JM, Hashimoto Y., et al: Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergystic combinations in venous thrombosis models in dogs and rabbits. Blood73:1207-1212, 1989.
6.
Topol EJ, Califf RM, George BS, et al: Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. Circulation77:1100-1107, 1988 .
